Respiratory syncytial virus (RSV) is increasingly recognized as a major pathogen in frail older adults and a cause of exacerbations of chronic obstructive pulmonary disease (COPD). Although there are studies examining the burden in hospitalized COPD cohorts, there has been no work evaluating the burden in the outpatient setting in this group.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Hyperhidrosis: Keep a Cool Head
An Overview of Important Treatment Options
- This article was sponsored by Johnson & Johnson.
Give your patients a chance to live longer without progression with TECVAYLI® + DARZALEX® compared to DPd/DVd1
- Sjögren's Syndrome in Early Childhood
Children often develop lymphomas
- Multidrug-Resistant Pathogens in Wound Care
An Enemy in the Microbiome?
- Rare Genodermatoses: From Diagnosis to Treatment
Darier’s Disease, also known as Follicular Keratosis – Update 2026
- Psychedelic-assisted therapy
Current status of PAT
- Osgood-Schlatter Disease
Clinical Presentation, Diagnosis, and Treatment
- Cardiovascular Risk in Rheumatoid Arthritis